These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36154346)

  • 1. Computational modeling of hypercoagulability in COVID-19.
    Zhu G; Modepalli S; Anand M; Li H
    Comput Methods Biomech Biomed Engin; 2023 Feb; 26(3):338-349. PubMed ID: 36154346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
    Vottero P; Tavernini S; Santin AD; Scheim DE; Tuszynski JA; Aminpour M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: Not a thrombotic disease but a thromboinflammatory disease.
    He S; Blombäck M; Wallén H
    Ups J Med Sci; 2024; 129():. PubMed ID: 38327640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability.
    van de Berg TW; Hulshof AM; Nagy M; van Oerle R; Sels JW; van Bussel B; Ten Cate H; Henskens Y; Spronk HMH;
    Thromb Res; 2021 May; 201():84-89. PubMed ID: 33662799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
    Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiphysics and multiscale modeling of microthrombosis in COVID-19.
    Li H; Deng Y; Li Z; Dorken Gallastegi A; Mantzoros CS; Frydman GH; Karniadakis GE
    PLoS Comput Biol; 2022 Mar; 18(3):e1009892. PubMed ID: 35255089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study.
    Hvas CL; Larsen JB; Adelborg K; Christensen S; Hvas AM
    Semin Thromb Hemost; 2022 Feb; 48(1):31-54. PubMed ID: 34715692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
    Fan BE; Ramanathan K; Sum CLL; Christopher D; Chan SSW; Lim GH; Bok CF; Wong SW; Lye DC; Young BE; Lim JY; Lee RM; Lim SP; Tan HT; Ang MK; Lau SL; Kuperan P; Ong KH; Chia YW
    J Thromb Thrombolysis; 2022 Apr; 53(3):646-662. PubMed ID: 34581945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 1 as a potential therapeutic target for COVID-19.
    Rovai ES; Alves T; Holzhausen M
    Exp Biol Med (Maywood); 2021 Mar; 246(6):688-694. PubMed ID: 33302737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.
    Girard TJ; Antunes L; Zhang N; Amrute JM; Subramanian R; Eldem I; Remy KE; Mazer M; Erlich EC; Cruchaga C; Steed AL; Randolph GJ; Di Paola J
    J Thromb Haemost; 2023 Mar; 21(3):629-638. PubMed ID: 36696180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
    Haimei MA
    Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.